Research Article

[Retracted] Meta-Analysis of the Effectiveness and Safety of Glucocorticoid for the Treatment of IgA Kidney Disease

Table 3

Effect of glucocorticoid on IgA nephropathy patients with proteinuria greater than 1.50 g/d.

Glucocorticoid groupControl groupStd. mean difference
Study or subgroupMeanSDTotalMeanSDTotalWeightIV, fixed, 95% CI

Locatelli et al., 20010.670.5431.481.874360.7%−0.59 [−1.02,−0.15]
Moriyama et al., 20041.020.98201.282.194039.3%−0.14 [−0.67, 0.40]
Total (95% CI)6383100.0%−0.41 [−0.75,−0.07]

Heterogeneity: Chi’ = 1.64, df = 1 ( = 0.20); I2 = 39%. Test for overall effect: Z = 2.38 ( = 0.02).